Alternatives to Evotec

AI-native drug discovery: phenomics, robotics, and a 50+ petabyte dataset to de-risk medicines.

Highly selective small-molecule drug discovery for oncology, immunology, and metabolic diseases.

End-to-end generative AI drug discovery platform from target ID to clinical trials, validated by a Phase III pipeline.

All-in-human AI foundation models for precision neurology and CNS drug discovery

Generative AI and robotics for autonomous drug discovery, compressing the DMTA cycle to under two years.

Physics-based molecular discovery platform for drug and materials design

AI drug discovery knowledge graph for target identification and drug repurposing.

AI-native drug discovery platform turning 50+ PB of cellular imaging data into clinical-stage therapies

AI-driven drug discovery platform combining 50+ PB of proprietary data with automated wet labs to design and validate optimized molecules.

AI co-scientist for biomedical research: multi-omics, drug discovery, and lab protocol reasoning

AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery

Open-source AI drug discovery assistant for molecular research

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data.

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

AI-driven biomanufacturing for personalized stem cell therapies

Enterprise AI pathology platform for diagnostics and drug development.

AI scientist delivering defendable drug program decisions in 2–5 days.

AI foundation models predicting patient drug response to de-risk clinical trials

AI-driven scientific diligence for pharma, biotech, and investment decisions.

AI target discovery platform for neurotherapeutics across disorders

AI-designed multivalent nanoparticles for cell-selective drug delivery

Owkin's K Pro: an autonomous AI scientist for biopharma R&D decision-making

Mechanistic interpretability platform to understand, debug, and design AI models

Oncology real-world evidence platform turning patient data into AI-powered insights for cancer research and care.

AI-driven clinical trial patient matching and recruitment from EMR data.

Regulatory-cleared quantitative imaging biomarkers from MRI, CT, and PET for radiology and biopharma

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

AI-native biotech accelerating small-molecule drug discovery from design to clinic

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

ML-guided protein engineering platform for multi-property co-optimization with compounding models from your own experimental data